Orchestra BioMed Ownership 2024 | Who Owns Orchestra BioMed Now?
Institutional Ownership
60.10%
Insider Ownership
22.63%
Retail Ownership
17.27%
Institutional Holders
22.00
Orchestra BioMed Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.12% | 399,712 | -60,229 | -13.09% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.09% | 233,344 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 18,076 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 24,783 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 24,708 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,933 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,112,731 | -426,471 | -27.71% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 39,198 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,396 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,174 | -778 | -5.58% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 8,414 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 6,693 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,178 | -1,164 | -18.35% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 748 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 4,591 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,400 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 4,904 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 7,296 | - | - | Mar 28, 2024 |
| BLACKROCK FUNDS | 0.00% | 262,308 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 4,988 | -2,127 | -29.89% | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 36,543 | -701 | -1.88% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 480,282 | -27,596 | -5.43% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,999 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 300 | -500 | -62.50% | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,396 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 113 | -10 | -8.13% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 38 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,006 | -100 | -9.04% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 19,629 | -1,105 | -5.33% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 901 | 116 | 14.78% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 13,100 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 17,537 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 19 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,651 | -6 | -0.36% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 12,006 | 6,196 | 106.64% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 7,471 | 1,113 | 17.51% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 19,166 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 29,328 | -543 | -1.82% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 2,453 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,709 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,832 | 211 | 13.02% | Jan 31, 2024 |
Orchestra BioMed's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 399.71K shares, compromising 0.12% of its total assets.
Orchestra BioMed Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 22 | 2100.00% |
| 31 Dec, 22 | 1 | - |
As of 31 Mar 23, 22 institutions are holding Orchestra BioMed's shares, representing an increase of 2100.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 9,872,658 | 1339.58% |
| 31 Dec, 22 | 685,801 | - |
Orchestra BioMed (OBIO) has 9.87M shares outstanding as of 31 Mar 23, up 1339.58% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 60.10% | 1102.64% |
| 31 Dec, 22 | 5.00% | - |
As of 31 Mar 23, Orchestra BioMed is held by 60.10% institutional shareholders, representing a 1102.64% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | - | - |
| 31 Dec, 22 | - | - |
- institutional shareholders have increased their position in OBIO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | - |
| 31 Dec, 22 | - | - |
1 institutional shareholders have reduced their position in OBIO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 22 | 2100.00% | 9,872,658 | 1339.58% | 60.10% | 1102.64% | - | - | 1 | - |
| 31 Dec, 22 | 1 | - | 685,801 | - | 5.00% | - | - | - | - | - |
Orchestra BioMed Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Orchestra BioMed's stock was made by HSAC 2 Holdings, LLC on Aug 07 2024, selling 3,405,251 shares at - per share (valued at -). The last insider buy of OBIO was made by Hochman David P on Aug 15 2024, buying 2,500 shares at $5.84 per share (worth $14.60K).
Orchestra BioMed Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 1 | 300.00% |
| Q2 2024 | 25 | - | - |
| Q1 2024 | 2 | 1 | 200.00% |
| Q4 2023 | - | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | 94 | 9 | 1044.44% |
3 total buy trades, and 1 total sell trades (buy/sell ratio of 3.00%) were made by Orchestra BioMed's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 4 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
As of Q3 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Orchestra BioMed's stocks.
OBIO Ownership FAQ
Who Owns Orchestra BioMed?
Orchestra BioMed is owned by institutional shareholders (60.10%), insiders (22.63%), and public (17.27%). The largest institutional shareholder of Orchestra BioMed is (0% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.12% of total shares).
How many Orchestra BioMed shareholders are there?
As of Mar 2023, there are 22 institutional shareholders of Orchestra BioMed.